These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1263 related articles for article (PubMed ID: 23570880)

  • 1. A rational, non-radioactive strategy for the molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Coeli-Lacchini FB; Turatti W; Elias PC; Elias LL; Martinelli CE; Moreira AC; Antonini SR; de Castro M
    Gene; 2013 Sep; 526(2):239-45. PubMed ID: 23570880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical phenotype and mutation spectrum of the CYP21A2 gene in patients with steroid 21-hydroxylase deficiency.
    Choi JH; Jin HY; Lee BH; Ko JM; Lee JJ; Kim GH; Jung CW; Lee J; Yoo HW
    Exp Clin Endocrinol Diabetes; 2012 Jan; 120(1):23-7. PubMed ID: 22020670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel deletion alleles carrying CYP21A1P/A2 chimeric genes in Brazilian patients with 21-hydroxylase deficiency.
    Coeli FB; Soardi FC; Bernardi RD; de Araújo M; Paulino LC; Lau IF; Petroli RJ; de Lemos-Marini SH; Baptista MT; Guerra-Júnior G; de-Mello MP
    BMC Med Genet; 2010 Jun; 11():104. PubMed ID: 20587039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular genetic analysis in 93 patients and 193 family members with classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency in Croatia.
    Dumic KK; Grubic Z; Yuen T; Wilson RC; Kusec V; Barisic I; Stingl K; Sansovic I; Skrabic V; Dumic M; New MI
    J Steroid Biochem Mol Biol; 2017 Jan; 165(Pt A):51-56. PubMed ID: 27041116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular CYP21A2 diagnosis in 480 Brazilian patients with congenital adrenal hyperplasia before newborn screening introduction.
    de Carvalho DF; Miranda MC; Gomes LG; Madureira G; Marcondes JA; Billerbeck AE; Rodrigues AS; Presti PF; Kuperman H; Damiani D; Mendonca BB; Bachega TA
    Eur J Endocrinol; 2016 Aug; 175(2):107-16. PubMed ID: 27185867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CYP21A2 mutation analysis in Korean patients with congenital adrenal hyperplasia using complementary methods: sequencing after long-range PCR and restriction fragment length polymorphism analysis with multiple ligation-dependent probe amplification assay.
    Hong G; Park HD; Choi R; Jin DK; Kim JH; Ki CS; Lee SY; Song J; Kim JW
    Ann Lab Med; 2015 Sep; 35(5):535-9. PubMed ID: 26206692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of genotypephenotype correlation in congenital adrenal hyperplasia due to a CYP21A2-like gene.
    Leccese A; Longo V; Dimatteo C; De Girolamo G; Trunzo R; D'Andrea G; Bafunno V; Margaglione M; Santacroce R
    Clin Chim Acta; 2014 Nov; 437():48-51. PubMed ID: 25025300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Development and application of a method for molecular diagnosis of 21-hydroxylase deficiency].
    Ma DY; Sun Y; Chen Y; Yang B; Cheng J; Huang ML; Zhang J; Zhang JJ; Hu P; Lin Y; Jiang T; Xu ZF
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2013 Feb; 30(1):49-54. PubMed ID: 23450479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genotyping of CYP21A2 for congenital adrenal hyperplasia screening using allele-specific primer extension followed by bead array hybridization.
    Oh Y; Park SW; Chun SM; Lim N; Ahn KS; Ka JO; Jin DK; Han BD
    Mol Diagn Ther; 2009 Dec; 13(6):397-405. PubMed ID: 19925038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic Characterization of a Cohort of Italian Patients with Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency.
    Concolino P; Perrucci A; Carrozza C; Urbani A
    Mol Diagn Ther; 2023 Sep; 27(5):621-630. PubMed ID: 37548905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotype and genotype correlation of the microconversion from the CYP21A1P to the CYP21A2 gene in congenital adrenal hyperplasia.
    Torres N; Mello MP; Germano CM; Elias LL; Moreira AC; Castro M
    Braz J Med Biol Res; 2003 Oct; 36(10):1311-8. PubMed ID: 14502362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiplex ligation-dependent probe amplification (MLPA) assay for the detection of CYP21A2 gene deletions/duplications in congenital adrenal hyperplasia: first technical report.
    Concolino P; Mello E; Toscano V; Ameglio F; Zuppi C; Capoluongo E
    Clin Chim Acta; 2009 Apr; 402(1-2):164-70. PubMed ID: 19263525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiplex ligation-dependent probe amplification assay for diagnosis of congenital adrenal hyperplasia.
    Jang JH; Jin DK; Kim JH; Tan HK; Kim JW; Lee SY; Ki CS; Park HD
    Ann Clin Lab Sci; 2011; 41(1):44-7. PubMed ID: 21325254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular analysis of the CYP21A2 gene in Chinese patients with steroid 21-hydroxylase deficiency.
    Ma D; Chen Y; Sun Y; Yang B; Cheng J; Huang M; Zhang J; Zhang J; Hu P; Lin Y; Jiang T; Xu Z
    Clin Biochem; 2014 Apr; 47(6):455-63. PubMed ID: 24503005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutational characterization of congenital adrenal hyperplasia due to 21-hydroxylase deficiency in Malaysia.
    Balraj P; Lim PG; Sidek H; Wu LL; Khoo AS
    J Endocrinol Invest; 2013 Jun; 36(6):366-74. PubMed ID: 23027774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CYP21A2 Gene Pathogenic Variants: A Multicenter Study on Genotype-Phenotype Correlation from a Portuguese Pediatric Cohort.
    Santos-Silva R; Cardoso R; Lopes L; Fonseca M; Espada F; Sampaio L; Brandão C; Antunes A; Bragança G; Coelho R; Bernardo T; Vieira P; Morais R; Leite AL; Ribeiro L; Carvalho B; Grangeia A; Oliveira R; Oliveira MJ; Rey V; Rosmaninho-Salgado J; Marques B; Garcia AM; Meireles A; Carvalho J; Sequeira A; Mirante A; Borges T;
    Horm Res Paediatr; 2019; 91(1):33-45. PubMed ID: 30889569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive mutation analysis of the CYP21A2 gene: an efficient multistep approach to the molecular diagnosis of congenital adrenal hyperplasia.
    Xu Z; Chen W; Merke DP; McDonnell NB
    J Mol Diagn; 2013 Nov; 15(6):745-53. PubMed ID: 24071710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microconversion between CYP21A2 and CYP21A1P promoter regions causes the nonclassical form of 21-hydroxylase deficiency.
    Araújo RS; Mendonca BB; Barbosa AS; Lin CJ; Marcondes JA; Billerbeck AE; Bachega TA
    J Clin Endocrinol Metab; 2007 Oct; 92(10):4028-34. PubMed ID: 17666484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three novel CYP21A2 mutations and their protein modelling in patients with classical 21-hydroxylase deficiency from northeastern Iran.
    Baradaran-Heravi A; Vakili R; Robins T; Carlsson J; Ghaemi N; A'rabi A; Abbaszadegan MR
    Clin Endocrinol (Oxf); 2007 Sep; 67(3):335-41. PubMed ID: 17573904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [CYP21 gene point mutations study in 21-hydroxylase deficiency patients].
    Liao XY; Zhang YF; Gu XF
    Zhonghua Er Ke Za Zhi; 2003 Sep; 41(9):670-4. PubMed ID: 14733808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 64.